NDC product
Memantine Hydrochloride
NDC 0832-1113 · Upsher-Smith Laboratories, LLC
Key facts
| Product NDC | 0832-1113 |
|---|---|
| Proprietary name | Memantine Hydrochloride |
| Nonproprietary name | Memantine Hydrochloride |
| Substances | MEMANTINE HYDROCHLORIDE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Upsher-Smith Laboratories, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA090043 |
| Pharmacologic classes | N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA] |
| Marketing start | Jul 31, 2015 |
| Marketing end | Jan 31, 2028 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory